I012 PRIA Fee Category

An application that proposes a new non-food use for a safener (a chemical that selectively protects crop plants against herbicide injury) inert ingredient that is not currently approved for non-food use and is accompanied by the submission of supporting data (e.g., toxicity data, environmental fate data, ecotoxicity data). A non-food use includes a proposed use that is not a food use as described in the food use categories. Non-food uses could include treatment of ornamentals, turf uses, structural protection, residential use, cooling tower treatments, aquatic area application (e.g., wastewater treatment), oil fields (marine and terrestrial), sewage treatment plants (water is treated prior to discharge into the environment), wood preservatives, antifoulants, ballast water, residential use (e.g., carpet sanitizer, hard surface disinfectant), commercial, institutional, industrial premise and equipment (e.g. offices, hotels, industrial buildings, nursing homes), agricultural premise treatment (e.g., farm structures, buildings and equipment, animal drinking water), materials preservatives (e.g., adhesives, coatings, plastic, fabric), industrial processes and water systems treatment (e.g., reverse osmosis water systems, recirculating cooling tower systems, evaporative condensers), medical premises and equipment (e.g., dental equipment, dental unit water lines, hospitals), HVAC, swimming pools, and spas. Prior to a submission under this category, OPP highly recommends the applicant request a meeting with the Agency to discuss data needs. 

If another covered application intends to associate with and depend upon an already pending application for a safener approval in this category, the dependent application must identify the pending safener approval action with its inert approval tracking number assigned by the Agency, name of the safener that is pending and the safener’s applicant’s name. Due to CBI concerns, the Agency will not provide information to the applicant of the dependent covered application regarding the status of the pending safener approval action beyond information that must be shared to adjust decision review times for the dependent application as discussed below. All other information on the safener’s approval action MUST come from the safener applicant.

If a new safener is submitted in the same package as a new active ingredient, and that new active ingredient is determined to be reduced risk, then the safener would get the same reduced timeframe as the new active ingredient.

The decision review time due date for the dependent covered application will be extended to match the decision review time due date of the pending safener approval action, unless the decision review time due date for the dependent covered application is further out, in which case the dependent covered application will initially be subject to its own decision review time.